CD8A and neoplasm: Most importantly, MAPK-mutant HNSCC tumors are the only tumors having significant “CD8+ T-cell–inflamed” and inherently immunoactive tumor microenvironment (versus six other pathway-mutant tumors), with constitutive cytolysis.